Skip to main content
SpringerLink
Log in

Cellular Protein and mRNA Expression Patterns of Matrix Metalloproteinases-2, -3 and -9 in Human Breast Cancer: Correlation with Tumour Growth

  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

The expression of matrix metalloproteinases (MMPs) with type IV collagenase activity has been associated with tumour invasion and metastatic potential in experimental models. We studied whether the cellular localization of MMP expression provides useful information on tumour behaviour in human breast cancer.

Immunohistochemistry and non-radioisotopic-detected in situ hybridization were used to study protein and mRNA expression profiles for MMPs-2, -3 and -9 in paraffin sections of 70 invasive breast carcinomas.

Protein and mRNA expression of the MMPs was observed in tumour as well as in peritumoural stromal cells. MMP protein expression was increased at the invasive border (p < 0.05). Grade 3 carcinomas expressed MMP-2 mRNA in significantly more tumour cells than grade 2 carcinomas (p = 0.006). Ductal carcinomas with an extensive intraductal component were characterized by the lowest percentages of MMPs-2 and -3 mRNA expressing peritumoural stromal cells (p < 0.05). No correlation was observed between MMP protein/mRNA expression and pTNM classification.

In conclusion our results indicate that the expression of MMPs is associated with tumour behaviour. The correlation of MMPs-2 and -3 expression in peritumoural stromal cells with tumour type, shown for the first time, suggests that transcriptional regulation of these MMPs in stromal cells is important for the growth pattern of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alessandro R, Minafra S, Pucci-Minafra I, Onisto M, Garbisa S, Melchiori A, Tetlow L, Woolley DE (1993) Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer 55: 250-255.

    Google Scholar 

  • Alvarez OA, Carmichael DF, DeClerck YA (1990) Inhibition of col-lagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82: 589-595.

    Google Scholar 

  • Birembaut P, Caron Y, Adnet JJ, Foidart JM (1985) Usefulness of basement membrane markers in tumoural pathology. J Pathol 145: 283-296.

    Google Scholar 

  • Brown PD, Bloxidge RE, Anderson E, Howell A (1993) Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11: 183-189.

    Google Scholar 

  • Brummer O, Athar S, Riethdorf L, Loning T, Herbst H (1999) Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: An in situ hybridization study. Virchows Arch 435: 566-573.

    Google Scholar 

  • Cam Y, Bellon G, Poulin G, Caron Y, Birembaut P (1984) Distribution of type IV collagen in benign and malignant epithelial proliferations. An indirect immunofluorescence study on the breasts, the lungs, and the skin. Invasion Metastasis 4: 61-72.

    Google Scholar 

  • Chambers AF, Matrisian LM(1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270.

    Google Scholar 

  • Clavel C, Polette M, Doco M, Binninger I, Birembaut P (1992) Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bull Cancer 79: 261-270.

    Google Scholar 

  • Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.

    Google Scholar 

  • Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA, Grigioni WF (1991) Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 48: 529-532.

    Google Scholar 

  • Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M (2000) Gelatinase A, membrane type 1 matrix metalloproteinase, and extracel-lular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer. World J Surg 24: 334-340.

    Google Scholar 

  • Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR (1993) Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131

    Google Scholar 

  • Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-410.

    Google Scholar 

  • Garbett EA, Reed MW, Stephenson TJ, Brown NJ (2000) Proteolysis in human breast cancer. Mol Pathol 53: 99-106.

    Google Scholar 

  • Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA (1987) Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res 47: 1523-1528.

    Google Scholar 

  • Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, Klebe RJ (1998) Overviewof matrix metalloproteinase expression in cultured human cells. Matrix Biol 16: 483-496.

    Google Scholar 

  • Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH(1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273-282.

    Google Scholar 

  • Ioachim EE, Kamina S, Kontostolis M, Agnantis NJ (1997) Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and prolifera-tive indices in breast cancer. Virchows Arch 431: 311-316.

    Google Scholar 

  • Ioachim EE, Athanassiadou SE, Kamina S, Carassavoglou K, Agnantis NJ (1998) Matrix metalloproteinase expression in human breast cancer: An immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices. Anticancer Res 18: 1665-1670.

    Google Scholar 

  • Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y(1996) Production of matrix metalloproteinases and tissue inhibitors of met-alloproteinases in human breast carcinomas. Jpn J Cancer Res 87: 602-611.

    Google Scholar 

  • Jones JL, Royall JE, Walker RA (1996) E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237-1241.

    Google Scholar 

  • Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189: 161-168.

    Google Scholar 

  • Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Lohrs U(1999) Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Anticancer Res 19: 4257-4264.

    Google Scholar 

  • Lichtinghagen R, Helmbrecht T, Arndt B, Boker KH (1995) Expression pattern of matrix metalloproteinases in human liver. Eur J Clin Chem Clin Biochem 33: 65-71.

    Google Scholar 

  • Llorens A, Rodrigo I, Lopez-Barcons L, Gonzalez-Garrigues M, Lozano E, Vinyals A, Quintanilla M, Cano A, Fabra A (1998) Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab Invest 78: 1131-1142.

    Google Scholar 

  • Moll R, Mitze M, Frixen UH, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742.

    Google Scholar 

  • Nakajima M, Welch DR, Belloni PN, Nicolson GL(1987) Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869-4876.

    Google Scholar 

  • Nakopoulou L, Giannopoulou I, Gakiopoulou H, Liapis H, Tzonou A, Davaris PS (1999) Matrix metalloproteinase-1 and-3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 30: 436-442.

    Google Scholar 

  • Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 18: 1135-1149.

    Google Scholar 

  • Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Dano K (1997) Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest 77: 345-355.

    Google Scholar 

  • Pacheco MM, Mourao M, Mantovani EB, Nishimoto IN, Brentani MM (1998) Expression of gelatinases Aand B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations. Clin Exp Metastasis 16: 577-585.

    Google Scholar 

  • Polette M, Gilbert N, Stas I, Nawrocki B, Noel A, Remacle A, Stetler-Stevenson WG, Birembaut P, Foidart M (1994) Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using con-focal microscopy. Virchows Arch 424: 641-645.

    Google Scholar 

  • Ponder BA (2001) Cancer genetics. Nature 411: 336-341.

    Google Scholar 

  • Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM, Rogers L, Stamp GW (1993) Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46: 429-436.

    Google Scholar 

  • Remacle AG, Noel A, Duggan C, McDermott E, O'Higgins N, Foidart JM, Duffy MJ (1998) Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer 77: 926-931.

    Google Scholar 

  • Ries C, Lottspeich F, Dittmann KH, Petrides PE (1996) HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases. Leukemia 10: 1520-1526.

    Google Scholar 

  • Rosen PP, Oberman HA (1993) Tumors of the Mammary Gland. Washington DC.: AFIP.

    Google Scholar 

  • Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris JR (1994) The relationship between microscopic margins of resection and the risk of local recur-rence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74: 1746-1751.

    Google Scholar 

  • Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M (2001) Overexpression of matrix-metalloproteinase-9 in human breast cancer: A potential favourable indicator in node-negative patients. Br J Cancer 84: 1488-1496.

    Google Scholar 

  • Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L (2001) Breast stroma plays a dominant regulatory role in breast epithelial growth and. differentiation: Implications for tumor development and progression. Cancer Res 61: 1320-1326.

    Google Scholar 

  • Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K, Seifert M, Kubista E (2002) MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 72: 69-77.

    Google Scholar 

  • Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A, Autio-Harmainen H (1994) 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization. J Histochem Cytochem 42: 945-951.

    Google Scholar 

  • Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146.

    Google Scholar 

  • Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T (1998) Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast car-cinoma. Cancer 83: 1153-1162.

    Google Scholar 

  • Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T (1999) MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma. Breast Cancer Res Treat 58: 287-293.

    Google Scholar 

  • Talvensaari-Mattila A, Paakko P, Blanco-Sequeiros G, Turpeenniemi-Hujanen T(2001) Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. Breast Cancer Res Treat 65: 55-61.

    Google Scholar 

  • Tavassoli FA(1999) Ductal intraepithelial neoplasia: Risk factors for sub-sequent development of invasive carcinoma. Pathology of the Breast. Stamford CT: Appleton & Lange, pp. 205-324.

    Google Scholar 

  • Tlsty TD, Hein PW (2001) Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11: 54-59.

    Google Scholar 

  • Tryggvason K, Hoyhtya M, Pyke C (1993) Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24: 209-218.

    Google Scholar 

  • Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055-2060.

    Google Scholar 

  • UICC (1997) TNM Classification of Malignant Tumours. New York: Wiley-Liss. Inc.

    Google Scholar 

  • Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, Fridman R (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast car-cinomas correlates with tumor recurrence. Int J Cancer 59: 339-344.

    Google Scholar 

  • Wiedorn KH, Goldmann T, Henne C, Kuhl H, Vollmer E (2001) EnVision +, a new dextran polymer-based signal enhancement tech-nique for in situ hybridization (ISH). J Histochem Cytochem 49: 1067-1071.

    Google Scholar 

  • Yu M, Sato H, Seiki M, Thompson EW (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55: 3272-3277.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathologisches Institut der Ludwig-Maximilians-Universität, Thalkirchner Straße 36, 80337, München, Germany

    Annette Lebeau, Claudia Müller-Aufdemkamp, Clarissa Allmacher, Ulrich Sauer & Udo Löhrs

  2. Institut für Pathologie, Städtisches Krankenhaus München-Bogenhausen, Englschalkinger Straße 77, 81925, München, Germany

    Andreas Nerlich

  3. Institut für Klinische Chemie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    Ralf Lichtinghagen

Authors
  1. Annette Lebeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Müller-Aufdemkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clarissa Allmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ulrich Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Nerlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ralf Lichtinghagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Udo Löhrs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lebeau, A., Müller-Aufdemkamp, C., Allmacher, C. et al. Cellular Protein and mRNA Expression Patterns of Matrix Metalloproteinases-2, -3 and -9 in Human Breast Cancer: Correlation with Tumour Growth. Histochem J 35, 443–455 (2004). https://doi.org/10.1023/B:HIJO.0000045943.26251.24

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:HIJO.0000045943.26251.24

Keywords

Search

Navigation